Z-0258-2025 Class III Ongoing

Recalled by DRG International, Inc. — Springfield, NJ

FDA device recall Z-0258-2025 was initiated by DRG International, Inc. on Sep 13, 2024 and is designated Class III. Reason for recall: The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the… The recall status is ongoing. Affected quantity: 504 units.

Recall details

Product Type
Devices
Report Date
Nov 6, 2024
Initiation Date
Sep 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
504 units

Product description

17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292

Reason for recall

The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

Distribution pattern

AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam

Code information

Lot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0258-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0258-2025. Report a data issue: hello@regdatalab.com.